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Abstract 
Purpose: This paper discusses the implementation and evaluation of a cognitive behavioral 
therapy (CBT) training course for clinicians in Chiba, the sixth-largest province in Japan.  
Design/methodology/approach: Individual CBT for obsessive-compulsive disorder, bulimia 
nervosa, or social anxiety disorder was delivered by trainees of the Chiba CBT training course 
in a single study design.  
Findings: The results demonstrated that individual CBT delivered by trainees led to 
statistically significant reductions in symptom severity for all three disorders. Feedback from 
the trainees indicated that the training course achieved its aims. 
Implications: Barriers to the dissemination of CBT in Japan such as opportunities for training 
and possible solutions are discussed. 
Originality: This paper evaluates the Chiba CBT training course, which is a Japanese 
adaptation of the UK Improving Access to Psychological Therapies Project and the first post-
qualification CBT training course in Japan. 
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Introduction 
Barriers to the dissemination of CBT 
Among evidence-based treatments, forms of cognitive behavior therapy (CBT) have 
been consistently shown to be effective across a wide range of disorders. While some studies 
have demonstrated the clinical effectiveness of cognitive behavior therapy for adults in 
routine clinical practice (e.g., Westbrook & Hill, 1998; Westbrook & Kirk, 2005), several 
authors have noted that evidence of the effectiveness of empirically supported treatments in 
routine practice is rarely available, and often, the evidence may be delivered suboptimally (e.g. 
Andrews & Titov, 2009; Gunter & Whittal, 2010; Shafran et al., 2009).  
Shafran et al. (2009) identified two barriers to the dissemination of CBT. First, 
commonly held beliefs, such as ‘Research trials have limited applicability to clinical practice’ 
and ‘Non-specific therapist effects are more important than specific interventions’, hamper the 
availability of CBT. Second, gaps in the current knowledge about training, measuring 
competence, key factors in the etiology or maintenance of the treated disorder, and the 
minimum dose required for treatment, limit the widespread adoption of the protocols to 
clinical settings (Shafran et al., 2009). Gunter and Whittal (2010) also identified various 
barriers to the wide-scale dissemination of CBT for anxiety disorders, including those that are 
applicable to empirically supported treatments in general (e.g. lack of training opportunities, 
failure to address practitioner concerns), as well as those that may be specific to CBT for 
anxiety disorders (e.g. practitioner concerns about using exposure interventions). To 
overcome these barriers, Gunter and Whittal (2010) advise continuing the accumulation of 
research-based data, advocating and appealing for the required funding and organisational 
support, and training practitioners to deliver CBT treatments. Advocates of CBT for anxiety 
disorders will also need to demonstrate that these treatments are cost effective if wide-scale 
dissemination is to occur. 
In order to address the severe under-provision of treatments and the dissemination of 
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CBT, the UK government has instigated a highly ambitious program, Improving Access to 
Psychological Therapies (IAPT), by funding the implementation of NICE guidelines for people 
suffering from depression and anxiety disorders in England. The IAPT program aims to 
address the under-provision of these treatments by training 3600 new psychological 
therapists between 2008–2011, which will provide 900,000 people access to treatment, with 
half of those engaging in treatment moving to recovery, and 25,000 fewer sick pay and 
medical benefit expenditures by 2010/11. Initial evaluation of two UK demonstration sites, 
Doncaster and Newham (Clark et al., 2009) has been published, and a two-year prospective 
cohort study was carried out to assess the impact of implementing empirically supported 
stepwise psychotherapy programs in routine practice in northern England (Richards & 
Borglin, 2011). 
 
Status of mental healthcare and CBT in Japan 
Awareness of the effectiveness of CBT has spread in Japan, not only among 
professionals and academics but also to the public through media (e.g., books, newspapers, 
TV). In April 2010, the inclusion of CBT for mood disorders in the national health insurance 
scheme marked a milestone for psychiatric care in Japan, where pharmacotherapy has 
historically been much more common. The inclusion of CBT in Japan’s insurance program is 
boosting CBT research through randomized controlled trials and facilitating training and 
practice in this field. However, many obstacles must still be overcome. For example, CBT for 
mood disorders is covered by national health insurance only if it is provided by medical 
doctors. Thus, patients bear all costs when other mental health professionals (e.g., clinical 
psychologists) conduct CBT. In addition, CBT for other mental health problems—such as 
anxiety disorders—are not yet covered by national health insurance. Most importantly, there 
are few competent CBT therapists in Japan, mainly because the opportunities for training are 
extremely limited compared to the UK supervision structure in the IAPT services. There are 
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workshops during annual conferences, and several institutions, such as the Tokyo CBT 
Academy and the National Centre for Cognitive Behavior Therapy and Research, regularly 
provide a series of workshops. However, only a limited number of clinicians can attend such 
training because it is primarily in Tokyo. Moreover, the total training time is relatively short 
(2–50 hours), and supervision is not provided (even when available, it is not provided on a 
regular basis).  
 
Chiba University training course 
Chiba University was founded in 1949 by uniting several regional national colleges and 
schools, including the Chiba Medical College. The university is located in Chiba province, 
which has a population of approximately six million—the sixth largest among the 47 
provinces in Japan. In 2010, the Graduate School of Medicine at Chiba University set up a CBT 
training course, the first post-qualification course for CBT in Japan. Trainees who enroll in the 
course are required to attend a series of workshops held over two years. The training day 
typically consists of a 3-hour workshop in the morning, and a 90-minute clinical case 
conference, and 60-minute group supervision in the afternoon. In addition, trainees receive 
30-minute individual supervision. The full course of training includes more than 400 hours. 
This training course started in April 2010 with three supervisors (two psychiatrists and one 
psychologist) and 18 trainees; however, the numbers of supervisors and trainees are 
increasing. Most trainees work in Chiba province and are psychiatrists, psychologists, 
psychiatric social workers, nurses, and pharmacologists. 
Our training course was inspired and influenced by the IAPT Project in the UK; our 
project aims to disseminate CBT in Chiba province and to increase the number of CBT 
therapists equivalent to the “high-intensity practitioners” in the UK. Similar to the 
accreditation for high-intensity practitioners, our trainees are required to complete 200 hours 
of clinical practice, receive 70 hours of supervision, and complete written reports for a 
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minimum of eight cases. Along with the written reports, trainees are required to submit audio 
or a video record of the sessions, and their competence in each session is assessed by 
supervisors using the Revised Cognitive Therapy Scale (CTS-R: Blackburn et al., 2000). The 
major differences between the UK IAPT and our course are the frequency that trainees come 
to the university for the course and how this training is funded. Because the trainees do not 
receive government funding, they attend the course only once per week for two years, and 
their training is funded by their employers. For those with limited opportunity to conduct 
individual psychotherapy at their own workplaces, the course also provides placement at 
Chiba University Hospital, where trainees see patients with anxiety disorders or bulimia 
nervosa (BN). Furthermore, our course, unlike the UK IAPT, offers follow-up supervision 
sessions, in which trainees received 30-minute individual supervision once a month for one 
year after the completion of the course. Moreover, some trainees go on to a PhD course and 
continue to attend the program. 
 
Purpose of the present study 
The purpose of this study is to report the preliminary outcomes of individual CBT for 
obsessive–compulsive disorder (OCD), BN, and social anxiety disorder (SAD) delivered by the 
trainees at Chiba University Hospital. To reflect routine clinical practice, we included patients 
with comorbid mood disorders if OCD, SAD, or BN was the principal diagnosis. The outcomes 
of trainee-delivered CBT are used to measure the effectiveness of our training course. We 
predicted that CBT would be associated with decreased symptom severity. Additionally, a 
post-hoc survey was conducted to receive feedback from the trainees who completed the 
course.  
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Methods 
Design 
Between April 2010 and December 2011, patients were recruited by clinical referrals 
from both Chiba University Hospital and other local psychiatric hospitals and clinics; these 
patients were assessed by the supervisors at Chiba University Hospital using the Structured 
Clinical Interview for Axis I Disorders (SCID-I; First & Gibbon, 1997). Written informed 
consent was obtained from all participants. The criteria for inclusion in this study included a 
primary diagnosis of OCD, BN, or SAD according to the DSM-IV and 18–65 years of age. The 
exclusion criteria were psychosis, mental retardation, current high risk of suicide, substance 
abuse or dependence in the past six months, antisocial personality disorder, unstable medical 
condition, pregnancy, or lactation. 
After enrolling in the study, the patients were placed on a waiting list. The waiting 
period was not controlled because it was based on the availability of therapy rooms; the wait 
averaged 140.90 days (SD = 62.18) for OCD, 89.6 days (SD = 84.5) for BN, and 13.26 days (SD = 
3.21) for SAD. After the waiting period, the participants received a 50-minute individual CBT 
intervention for 12 weeks. Extra sessions were flexibly added, and termination of treatment 
was determined jointly by the participants and therapists in consultation with the supervisor. 
The average number of sessions per participant was 16.25 (SD = 3.77) for OCD, 13.75 (SD = 
2.87) for BN, and 13.89 (SD = 1.24) for SAD. Concominant medications were permitted if the 
dose remained stable throughout the study. Participants were assessed using the outcome 
measures at pre- (first session) and post-CBT (final session). 
This study was conducted at an outpatient clinic at Chiba University Hospital, which is 
used by trainees who have limited opportunities to conduct individual psychotherapy at their 
own workplaces. 
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Outcome measures 
The primary outcome measures were self-reported obsessive–compulsive symptoms, 
as measured by the Obsessive Compulsive Inventory distress scale (OCI; Foa et al., 1998); self-
reported bulimic symptoms, as measured by the Severity Scale of the Bulimic Investigatory 
Test, Edinburgh (BITE-SS; Henderson et al., 1987); and self-reported symptoms of social 
anxiety, as measured by the Liebowitz Social Anxiety Scale (LSAS; Liebowitz, 1987). 
General severity of mood and anxiety were measured by the standard measures used 
in the UK IAPT: the 9-item version of the Patient Health Questionnaire (PHQ-9; Kessler et al., 
2002), which has scores ranging from 0 to 27 and a recommended cut-off of ≥10 for 
distinguishing between clinical and non-clinical populations; and the 7-item version of the 
Generalized Anxiety Disorder scale (GAD-7; Lo we et al., 2008), which was originally developed 
to screen for GAD, but also has satisfactory sensitivity and specificity for the detection of other 
anxiety disorders. These scales are outcome measures commonly used in the UK. 
 
Therapists 
CBT was delivered by the trainees in the CBT training program. As a course 
requirement, they attended 30-minute individual supervision sessions once every two weeks 
and 60-minute weekly group supervision sessions, allowing both supervisors and other 
trainees to give support and assistance in planning future sessions.  
Twenty-two therapists participated in the present study (16 women and six men) with 
a mean age of 42.13 years (SD = 10.99). In this study, the trainees treated an average of 1.86 
patients; most therapiss were allocated 1 or 2 patients. In terms of clinical licenses, there were 
13 clinical psychologists, three psychiatrists, one general physician, two psychosocial workers, 
and three nurses. The average number of years in practice as a clinician was 7.00 years (SD = 
6.95), and the average number of days of CBT workshop they had attended before enrolling in 
our course was 7.47 days (SD = 9.61). The clinical or therapeutic orientation they had used 
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most in their practice included psychodynamic (n = 1), CBT (n = 3), psychiatric (n = 3), 
counseling/client-centered (n = 6), integrated/eclectic (n = 7), or a combination of these 
orientations/other (n = 7). 
 
Interventions 
The main steps in the CBT treatment for OCD were:  
 Provision of psycho-education about the cognitive-behavioral model of OCD 
 Goal setting 
 Tailored case formulation 
 Exposure and response prevention 
 Homework 
 Relapse prevention  
Therapists were also permitted to use other intervention strategies as needed (e.g., 
Hougton et al., 2010), including behavioral experiments to test the validity of erroneous 
beliefs, opinion surveys, and ratings of mastery and pleasure. 
Our CBT program for BN was based on Maudsley’s model, “Getting Better Bite by Bite” 
(Schmidt & Treasure, 1993). Getting Better Bite by Bite is the only self-help program that has 
been evaluated in a randomized controlled trial and provides detailed, step-by-step advice for 
dealing with BN. The main steps in treatment were:  
 Guidelines for behavior change 
 Discussion of the pros and cons of maladaptive eating behaviors 
 Core values and goal setting 
 Psycho-education regarding nutrition, food, and weight 
 Self-monitoring using a food diary and provision of a structure for eating 
 Action plans on how to stop bingeing and purging behaviors 
 Identification of automatic thoughts and modification of maladaptive assumptions and 
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core beliefs 
 Behavioral experiments to challenge maladaptive beliefs 
 Progressive actions 
 Discussion of remaining challenges 
 Dealing with interpersonal difficulties 
 Relapse prevention.  
 Homework assigned after every session 
Our CBT program for SAD was based on the model of Clark and Wells (1995). The main 
steps in treatment were:  
 Developing an individualized version of the cognitive behavioral model of SAD 
 Conducting role-play–based behavioral experiments with and without safety behaviors 
 Restructuring distorted self-imagery using videotape feedback 
 Practicing external focus and shifting attention 
 Conducting behavioral experiments to test negative beliefs 
 Modifying problematic pre- and post-event processing 
 Discussing the difference between self-beliefs and other people’s beliefs (reflected in 
survey results) 
 Dealing with remaining assumptions (schema work) 
 Rescripting early memories linked to negative images in social situations 
 Preventing relapse  
 Homework assigned after every session 
 
Statistical analysis 
The outcomes of the CBT treatment were examined by the comparison of pre- and 
post-CBT scores of each scale (OCI, BITE-SS, LSAS, PHQ-9, and GAD-7) using within-group t-
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tests. Effect sizes were determined ([Mpre-CBT − Mpost-CBT]/SDre-baseline). According to Cohen 
(1988), the effect sizes were categorized as follows: small (0.20–0.49), medium (0.50–0.79), 
and large (0.80 and above). 
 
Feedback from trainees 
 A post-hoc survey via email was conducted with the trainees who took part in this 
study to obtain their feedback on the training course. They were asked to rate the following 
questions on a seven-point scale (ranging from very satisfied [7], satisfied [6], slightly 
satisfied [5], neutral [4], slightly dissatisfied [3], dissatisfied [2] to very dissatisfied [1]): 
1. How satisfied were you with the length (i.e., one day a week for two years) of the 
training course? 
2. How satisfied were you with the content and the delivery of the workshops? 
3. How satisfied were you with the frequency and the duration of the supervision? 
Additionally, they were asked to note the distinctive aspects of our training course compared 
to the CBT training they had previously and note any difficulties faced during the training.  
 
 
Results 
Results of patients with OCD  
Of the 21 patients screened, three were excluded because OCD was not their primary 
diagnosis (one OCPD, one adjustment disorder, and one hypochondriasis). Eighteen 
participants satisfied the study criteria and were referred to the study. During the waiting 
period, four patients declined the treatment without disclosing their reasons. Once the 
treatment started, the remaining 14 patients completed the study. 
Table 1 shows the baseline demographic and clinical variables of the 14 participants 
(Table 1). Eleven were women (79%), and the participants’ mean age was 36.79 years. Five 
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participants (36%) were unemployed, and six (43%) were single. All participants met the 
principal DSM-IV diagnostic criteria for OCD (mean duration: 5.21 years). Six participants 
(57%) also met the criteria for major depressive disorder as an additional Axis I diagnosis. 
Other clinical variables and participants’ demographics are shown in Table 1. 
Table 1 about here 
The primary outcome measure was the severity score of the OCI. The mean OCI score 
decreased from 64.43 (SD = 3.39) to 32.54 (SD = 17.49) over the course of treatment. The 
PHQ-9 and GAD-7 scores reduced from 8.57 (SD = 4.09) to 5.07 (SD = 4.29) and from 8.14 (SD 
= 5.63) to 4.07 (SD = 2.84), respectively. A within-group t-test revealed significantly different 
scores between the pre- and post-CBT scores on the assessed scales: t(1, 13) = 5.153, p < .001 
for the OCI; t(1, 13) = 2.775, p = .015 for the PHQ-9; and t(1, 13) = 3.277, p = .006 for the GAD-
7. The effect sizes between the pre- and post-CBT were 1.05 (large), .86 (large), and .72 
(medium) for the OCI, PHQ-9, and GAD-7, respectively. 
 
Results for patients with BN 
Of the 11 subjects screened, one was excluded from the study because her primary 
diagnosis was not BN (anorexia nervosa binge-eating/purging type). After enrolling in the 
study, no patients dropped out, but assessment data were not obtained from two patients. As a 
result, the data of eight patients were subject to analysis. 
Table 2 shows the baseline demographic information and clinical variables of the eight 
patients whose data were analyzed. All of the participants were female, and their mean age 
was 31.3 years. One patient was employed, three were students, and four were single. Four 
patients had comorbid psychiatric disorders: two had additional Axis I diagnoses of major 
depressive disorder, one had bipolar disorder, and one had SAD. Other clinical variables and 
participants’ demographics are shown in Table 2. 
Table 2 about here 
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The primary outcome measure was the severity score on the BITE-SS. The average 
BITE-SS score decreased from 9.75 (SD = 4.28) to 4.00 (SD = 4.34) over the course of the 
study. The PHQ-9 and GAD-7 scores reduced from 12.12 (SD = 7.70) to 8.13 (SD = 7.42) and 
from 9.38 (SD = 6.12) to 6.25 (SD = 6.67), respectively. A within-group t-test revealed 
significant differences between pre- and post-CBT in BITE-SS, t(1, 7) = 2.803, p = .026, and 
GAD-7 scores, t(1, 7) = 2.739, p = .028. However, there was no significant difference in the 
PHQ-9 scores over the course of the study, t(1, 7) = 1.782, p = .117. The effect sizes between 
pre- and post-CBT were 1.348 (large), .516 (medium), and .508 (medium) for the BITE-SS, 
PHQ-9, and GAD-7, respectively. 
 
Results for patients with SAD 
Of the 23 subjects screened, four were excluded: two had high risk of suicide, and the 
primary diagnoses of the other two were not SAD (autism spectrum disorders). As a result, 19 
patients met the enrolment criteria and were referred to the study. All patients completed the 
study.  
Table 3 shows the baseline clinical variables and demographics of the 19 patients who 
enrolled in this study (Table 3). Fourteen of the participants were women (74%), and the 
patients’ mean age was 32.3 years. Four patients (21%) were unemployed and 12 (63%) were 
single. All participants met the principal DSM-IV diagnostic criteria for SAD (mean duration: 
14.3 years). Patients with additional Axis I diagnoses included five (26%) who met the criteria 
for major depressive disorder, two (13%) for bipolar disorder type II, and one (5%) for panic 
disorder with agoraphobia.  
Table 3 about here 
The primary outcome measure was the severity score of the LSAS. The average LSAS 
score decreased from 87.05 (SD = 29.40) to 54.00 (SD = 29.99) over the course of the study. 
The PHQ-9 and GAD-7 scores reduced from 11.11 (SD = 6.88) to 6.84 (SD = 5.07) and 9.32 (SD 
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= 5.86) to 5.74 (SD = 4.74), respectively. A within-group t-test revealed significantly different 
scores between the pre- and post-CBT scores on the assessed scales: t(1, 18) = 5.627, p < .001, 
for the LSAS; t(1, 18) = 3.338, p = .003 for the PHQ-9; and t(1, 18) = 2.486, p = .002 for the 
GAD-7. The effect sizes between pre- and post-CBT were 1.124 (large), .620 (medium), and 
0.611 (medium) for the LSAS, PHQ-9, and GAD-7, respectively. 
 
Result of feedback from trainees  
 Ten trainees took part in the post-hoc survey about the training course. Regarding 
satisfaction with the length (i.e., one day a week for two years) of the training course, eight 
selected “satisfied,” and two selected “very satisfied.” As for the workshops, six selected 
“satisfied,” three selected “very satisfied,” and one selected “slightly satisfied.” With respect to 
the frequency and the duration of the supervision, five selected “satisfied,” three selected 
“slightly satisfied,” and two selected “satisfied.” 
In response the question about the distinctive aspects of our training course compared 
to previous CBT training, five mentioned the continuity and practicality of our course, in 
contrast to classroom lectures for a short period. Additionally, four trainees appreciated the 
colleagues they had made through the training, and noted that they still support each other. 
Moreover, two pointed out that they obtained a wider perspective of CBT because both 
psychologists and psychiatrists were instructors in the training course. Regarding the 
difficulties trainees had during the training, three referred to their reluctance to record the 
sessions, although their clients usually agreed to be recorded. Finally, two noted that it was 
difficult to write clinical case reports. 
 
Discussion 
The purpose of this study was to report the preliminary outcomes of individual CBT for 
OCD, BN, and SAD delivered by the trainees of the Chiba CBT training course. We included 
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patients with comorbid mood disorders if OCD, SAD, or BN was the principal diagnosis to 
reflect routine clinical practice. The results demonstrated that individual CBT for OCD, BN, and 
SAD in Japan led  to significant reductions in symptom severity for these primary diagnoses. 
The effect size for OCD was comparable with those obtained in past trials involving 
psychological treatment for OCD (Rosa-Alca zar et al., 2008), and those for BN and SAD were 
large. Our study was designed not only to recruit patients similar to those seen in routine 
clinical practice but also to train clinicians who will be engaged in routine clinical practice; 
they were not fully trained therapists before this study.  
Although it is difficult to directly compare our effect sizes with other published data 
due to a variety of factors (e.g., patient demographic and type/intensity of CBT), the overall 
effect sizes of 0.63 for PHQ-9 (medium) and 0.66 for GAD-7 (medium) were less than were 
those in other IAPT and other studies (Clark et al. 2009; Radhakrishnan et al. 2013; Richards 
& Borglin, 2011; Richards & Suckling, 2009; Westbrook & Hill, 1998; Westbrook & Kirk, 2005). 
It is possible that severity of depression and anxiety among our recruited patients was lower 
than that observed in previous reports, and thus resulted in a lower effect size. However, it is 
noteworthy that our results showed the lowest scores of PHQ-9 and GAD-7 at post-treatment 
(Table 4). 
Table 4 about here 
 Our training course was highly evaluated by the trainees regarding the satisfaction 
with the length of the training course, the content of the workshops, and the frequency and 
duration of the supervision. This was confirmed by their comments suggesting that our course 
offered more comprehensive training than other courses. The trainees valued colleagues, 
probably because most of them do not have someone to consult (even to talk) about CBT at 
their workplace. In order to address the difficulties in writing case reports, the supervisors 
addressed this issue by providing a special seminar about academic writing. 
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Dissemination of CBT across Japan 
As noted in the Introduction, CBT is only covered by national health insurance for the 
treatment of mood disorders, primarily because the quantity of outcome research in CBT, 
particularly using randomized control trials, is exceptionally low in Japan. As Gunter and 
Whittal (2010) proposed, we need to conduct studies and evaluate more research-based data 
to obtain required funding and organizational support. The other issue hindering the 
dissemination of CBT in Japan is the paucity of training opportunities. Opportunities are 
limited for both pre- and post-qualification training. More than 160 universities and colleges 
provide postgraduate master’s programs in clinical psychology, but only a few courses 
incorporate CBT in their curricula because of the scarcity of CBT experts. Our hope is that 
post-qualification training courses will be established in other areas of Japan so that more 
health professionals can attend workshops and benefit from regularly supervised practice.  
Through the development and administration of the training course, the supervisors 
gained a wealth of professional knowledge concerning the dissemination of CBT in Japan. For 
example, approximately two years before the commencement of the training course, a survey 
was conducted with a number of psychiatric hospitals and clinics in Chiba province to identify 
the type of therapies that patients desired and clinicians would like to learn (Haraguchi et al., 
submitted for publication). The result of this survey revealed the strong need for CBT and 
provided rationale for establishing our training course. Additionally, as they ran the training 
course, supervisors had to identify and solve problems and difficulties as these arose. For 
instance, some trainees had difficulties with academic writing because they had completed 
their undergraduate or postgraduate course many years ago. A special workshop was 
organized for the improvement of writing skills. To modify bias in their assessments, 
supervisors occasionally watched a video of a session together and compared each other’s 
scores on the CTS-R. Moreover, they asked their supervisees to rate the Process Evaluation of 
Training and Supervision scale (Wilson, 2007) to assess the duration, frequency, supportive, 
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and formative factors of supervision.  
The concept of CBT as a Western therapy requiring major adaptation for effective use 
in Japanese culture must be considered further in on-going research. Compared to Western 
cultures, more emphasis is placed on interpersonal relationships than on self-fulfillment or 
self-development in Asian cultures. However, we believe that similar factors support the 
efficacy and utilization of CBT in Japan. For example, in a randomized trial, Nakatani et al. 
(2005) demonstrated that behavioral therapy is highly effective for Japanese patients with 
OCD. Matsunaga et al. (2008) elucidated the transcultural stability of the symptom structure 
of OCD, which is consistent with the hypothesis that OCD is mediated by universal 
psychobiological mechanisms.  
 
The limitations of this study 
Although the present study provided valuable information, it does have several 
limitations. This was a single-arm study without a concurrent control group. Moreover, our 
waiting period was not fixed, and scores were not obtained at a pre-treatment baseline point. 
Although these design factors reflect the real-world nature of mental health services, it 
remains unknown whether the observed improvements in symptom severity was related to 
the natural extinction of the disorders. More studies employing psychological placebo 
conditions to control for nonspecific factors, such as positive outcome expectancy and self-
efficacy for problem management, are needed. 
This study established the acute effectiveness of the treatment, but the lack of follow-
up data limits the generalizability of the study (e.g., long-term effects, relapse rates). Further, 
there was no control for the patients’ use of medication, although our patient group had 
typically taken antidepressant medication for an extended period before referral to Chiba 
University Hospital. Again, this circumstance reflects the reality of the population of patients 
who access secondary mental health services in Japan. Further studies will need to include 
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fixed waiting periods, control groups, and long-term follow-up to provide more insight into 
the implementation of CBT in routine practice in Japan. Currently, our research team is 
running a randomized control trial for SAD (Yoshinaga et al., in press: trial number: 
UMIN000007552) and single-arm trials for OCD and BN with fixed waiting periods. Changes 
in employment status, such as fewer days absent from work, should be examined after 
completion of the therapy. This would be a crucial test of whether increased access to 
psychological therapies would largely pay for itself by reducing other depression- and anxiety-
related public costs (e.g., welfare benefits and medical costs) and increasing revenues (e.g., 
taxes, increased productivity). 
This study focused on the effectiveness of CBT delivered by trainees to evaluate our 
training program. However, it remains unknown if the result of the CBT is due to the training 
or whether trainees had been already competent. Thus, other measures could also be 
employed to gain a better understanding of the ways training should be provided. Comparing 
scores on the cognitive therapy awareness scale (Sudak et al., 2003)— a multiple-choice 
questionnaire (Maunder et al., 2008; Myles & Milne, 2004)—between pre- and post-training 
would reveal how competent trainees felt as they progressed through training. A video 
assessment task (Myles & Milne, 2004) would provide a more objective perspective of the 
trainee competence.  
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Tables 
Table 1.  
Demographic and clinical characteristics for OCDa (N = 14) 
 
Variable Value 
Gender, female, n (%)   11 (79) 
Age, years, mean (SD)   36.79 (9.88) 
Comorbid Axis I diagnosis, N (%) No comorbid condition (OCD only) 8 (57) 
  With comorbidity 6 (43) 
Age of onset, years, mean (SD)   31.57 (9.18) 
Duration of OCD, years, mean (SD)   5.21 (4.67) 
Employment status, N (%) Employed full-time 2 (14) 
  Part-time/homemaker 7 (50) 
  Unemployed 5 (36) 
Marital status, N (%) Single 6 (43) 
  Married 7 (50) 
  Dating 1 (7) 
Educational background, N (%) High school 3 (22) 
  Diploma 4 (28) 
  Degree 7 (50) 
Currently on medication, N (%) AD and/or BZ 12 (86) 
 
a Abbreviations: OCD = Obsessive–compulsive Disorder; BZ = 
Benzodiazepines; AD = Antipsychotics. 
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Table 2.  
Demographic and clinical characteristics for BNa (N = 8) 
 
Variable Value 
Gender, female, N (%) 
 
8 (100) 
Age, years, mean (SD)   31.3 (10.4) 
BMI (kg/m2)  23.5(5.7) 
Comorbid Axis I diagnosis, N (%) Without comorbidity (BN only) 5 (62.5) 
  With comorbidity 3 (37.5) 
Age of onset, years, mean (SD)   20.8 (7.1) 
Duration of BN, years, mean (SD)   10.4 (8.9) 
Employment status, N (%) Employed full-time 1 (12.5) 
  Full-time student 3 (37.5) 
  Homemaker 2 (25.0) 
  Unemployed 2 (25.0) 
Marital status, N (%) Single 5 (62.5) 
  Married 3 (37.5) 
  Divorced 2 (25.0) 
Educational background, N (%) Junior high school 0 (0) 
  High school 1 (12.5) 
  Diploma 3 (37.5) 
  Degree 4 (50.0) 
Currently on medication, N (%) BZ and/or AD and/or MS  5 (62.5) 
 
a Abbreviations: BN = Bulimia Nervosa; BZ = Benzodiazepines; AD = Antipsychotics; 
MS = Mood Stabilizers 
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Table 3.  
Demographic and clinical characteristics for SADa (N = 19) 
 
Variable Value 
Gender, female, N (%)   14 (74) 
Age, years, mean (SD)   32.3 (9.7) 
Subtype, generalized, N (%)   16 (84) 
Comorbid Axis I diagnosis, N (%) Without comorbidity (SAD only) 11 (58) 
  With comorbidity 8 (42) 
Age of onset, years, mean (SD)   17.9 (8.8) 
Duration of SAD, years, mean (SD)   14.3 (10.5) 
Employment status, N (%) Employed full-time 6 (32) 
  Full-time student 5 (26) 
  Part-time/homemaker 4 (21) 
  Unemployed 4 (21) 
Marital status, N (%) Single 12 (63) 
  Married 6 (32) 
  Divorced 1 (5) 
Educational background, N (%) Junior high school 2 (13) 
  High school 7 (37) 
  Diploma 6 (32) 
  Degree 4 (21) 
Currently on medication, N (%) AD and/or BZ 17 (87) 
 
a Abbreviations: SAD = Social Anxiety Disorder; BZ = Benzodiazepines; 
AD = Antidepressants 
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Table 4.  
Comparison of effect sizes among various studies 
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Abbreviations: CBT = Cognitive Behavioural Therapy; PHQ-9 = Patients Health Questionnaire-
9 items; GAD-7 = Generalized Anxiety Disorder-7 items; BDI = Beck Depression Inventory; 
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BAI = Beck Anxiety Inventory; Dep = Depressive disorder; Anx = Anxiety disorder; ES = 
Effect Size. 
a High = one-to-one, face-to-face psychological therapy; Low =  guided self-help (e.g., using 
books, leaflets or computer support) and goup psychoeducation. 
b Effect sizes (cohen’s d) for each study were recalculated using same formula. 
 
